Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma ...
Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma (rrMM) Announced Cincinnati Children's Applied Gene and Ce ...
Nexus has two core components: a context compiler and a composable retriever. The context compiler builds and organises knowledge around how your company operates. The composable retriever formats and ...
USC researchers built a memristor that works at 700C, surviving conditions that killed every Venus probe. TetraMem is commercialising the technology for AI inference.
As electric vehicle sales surge, a new crisis could emerge at the workshop. With legacy mechanics sidelined by complex ...
The early history of personal computers is stacked with systems such as the Apple II and the Commodore 64 that had the ...
Xos Inc. to Demonstrate the Charger Hub Live Before Senior AFGSC Leadership and Defense Decision-Makers on May 13 and 14 in Bossier City, ...
Unity Software Inc. ( U) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT Ladies and gentlemen, thank you for joining us, and welcome to the Unity Technologies Q1 Earnings Call. [Operator Instructions] ...
RS, a high-service global product and service solutions provider for industrial customers, offers the products, services, and ...
Agentic AI expands enterprise attack surfaces through broad permissions and unreviewed deployments, increasing lateral ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access launch of Complex Genes.
Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results